NCT01864525View on ClinicalTrials.gov

Effects of Octanoic Acid for Treatment of Essential Voice Tremor

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 22, 2016

Study Completion Date

March 31, 2017

Conditions
Essential Voice TremorVocal TremorVoice TremorEssential Tremor of Voice
Interventions
DRUG

Octanoic acid

DRUG

Inactive capsule

Trial Locations (1)

13210

Syracuse University & Upstate Medical University, Syracuse

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Syracuse University

OTHER

NCT01864525 - Effects of Octanoic Acid for Treatment of Essential Voice Tremor | Biotech Hunter | Biotech Hunter